Monday, December 23, 2024
HomeTagsINtRON

iNtRON

iNtRON to Seek a New Clinical Partner for SAL200 Endolysin

iNtRON Biotechnology announced that SAL200, a endolysin-based novel antibacterial treatment for Staph superbugs including MRSA, has come back to the market and is now...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics